헬스케어 업계 RFID : 시장 점유율 분석, 업계 동향과 통계, 성장 예측(2026-2031년)

According to Mordor Intelligence, the RFID market size in healthcare industry was valued at USD 18.63 billion in 2025 and estimated to grow from USD 21.9 billion in 2026 to reach USD 49.12 billion by 2031, at a CAGR of 17.55% during the forecast period (2026-2031).

This report is Segmented by Component (Tags and Labels, Readers/Antenna and More), Tag Frequency (LF, HF/NFC, UHF/RAIN, and More), Application (Asset Tracking, Patient and Staff Tracking, and More), End User (Hospitals, Pharmaceutical Manufacturers, and More), and Geography (North America, Europe, Asia Pacific, South America, and More). The Market Forecasts are Provided in Terms of Value (USD).

Insights and Trends of RFID Market in Healthcare Industry

RFID-enabled Drug Authentication to Curb Counterfeits

Serialization milestones under the FDA Drug Supply Chain Security Act now compel manufacturers, repackagers, and distributors to exchange electronic product data by staggered deadlines in 2025, driving hospitals and wholesalers toward RFID because 2D barcodes strain high-volume verification lines. Oracle and Avery Dennison recently launched an integrated replenishment platform that marries EPC tags with cloud analytics to automate stockouts, reflecting how solution vendors are packaging compliance and efficiency in a single workflow. European health systems face a parallel imperative, with falsified medicines costing EUR 10.2 billion (USD 11.0 billion) annually, adding a tangible ROI argument that transcends mere regulatory checkbox. The bottleneck remains data completeness; up to half of drug SKUs still lack full Electronic Product Code Information Services (EPCIS) attributes, demanding middleware that can reconcile legacy ERP feeds with serialized identifiers.

Automated Cold-Chain Compliance for Temperature-Sensitive Biologics

Temperature excursions account for an estimated USD 35 billion in annual drug wastage worldwide, pushing logistics providers to embed temperature-sensing RFID tags that trigger alerts before thresholds are breached. Recent tags incorporate ionic-liquid phase-change materials whose melting points can be tuned to the stability band of each biologic, allowing one label to span use cases from insulin to CAR-T therapies. The vaccine rollout during the pandemic validated hybrid architectures that pair RAIN RFID with BLE beacons, enabling chain-of-custody firmware to sync readings as containers pass hubs With biologics forecast to command a rising share of pipelines, regulators on both sides of the Atlantic now require temperature documentation across every node, converting RFID from nice-to-have to essential infrastructure.

Interference of UHF RFID with MRI/CT Imaging Suites

Hospitals aiming for wall-to-wall visibility face electromagnetic conflict between 860-960 MHz tags and imaging hardware. Zone-based architectures that power-down readers near magnet rooms add layers of middleware and raise commissioning costs. Alternative HF tags mitigate risk but sacrifice read distance, limiting their utility in large holding bays. Lack of cohesive regulatory guidance complicates procurement timelines, prompting many radiology departments to postpone rollouts until supplier documentation matures.

Other drivers and restraints analyzed in the detailed report include:

1. Rapid Adoption of UHF Tags in Real-Time Location Systems
2. AI-powered Inventory Optimisation in Operating Rooms
3. Capital-Intensive Retrofit of Legacy Pharmacy Dispensing Cabinets

For complete list of drivers and restraints, kindly check the Table Of Contents.

Segment Analysis

Tags and Labels captured 46.65% of the RFID Market in healthcare industry share in 2025 because every deployment starts with a physical identifier anchored to an item. However, Software and Analytics is pacing the segment with an 18.42% CAGR, signaling a shift toward platforms that interpret raw tag reads into actionable dashboards. Oracle's cloud-native middleware sits atop edge readers, triggering replenishment orders the moment par levels dip, thereby monetizing data rather than hardware. Readers and antennas remain indispensable, yet their growth rate is moderating as unit prices fall and multi-protocol devices stretch lifecycle utility. The Services slice is becoming consultative, guiding hospitals through workflow redesign, cybersecurity hardening, and change-management sequencing that ensure adoption sticks. Collectively, this mix illustrates why software is now the gravitational center of the RFID Market in healthcare industry .

Investment is tilting to artificial-intelligence modules that forecast demand spikes, flag utilization anomalies, and push predictive maintenance reminders. Those features elevate total cost-of-ownership arguments, persuading finance committees that payback periods sit well inside three years. Vendor selection gravitates toward platforms boasting open APIs that bind to electronic health records, enterprise resource planning, and biomedical engineering ticketing systems in one environment, supporting best-of-breed freedom without data silos.

The RFID Market in healthcare industry size for UHF/RAIN implementations stood highest in 2025 because those tags read hundreds of items across multiple rooms through standard passive portals. Economies of scale are accelerating as the RAIN Alliance tracked 44.8 billion chip shipments in 2023. Microwave tags, although nascent, recorded the swiftest trajectory at 19.02% CAGR as perioperative teams require centimeter-level pinpointing of scalpels and drill bits. HF/NFC tags occupy controlled-access environments like medication carts where short-range security adds value. LF continues in dialyzers and implants that must communicate through fluid or metal shielding, though volume remains niche.

Hospitals are converging on hybrid readers able to interrogate multiple frequencies, safeguarding against stranded assets when new clinical use cases materialize. Procurement teams favor antennas that adapt power output in response to zone risk, resolving interference concerns near imaging suites. The net effect is a portfolio where UHF remains backbone but microwave and HF carve premium footholds for precision and privacy scenarios.

Complete Report Scope:

• By Component
  • Tags and Labels
  • Readers / Antennas
  • Middleware / Edge Servers
  • Software and Analytics
  • Services
• By Tag Frequency
  • LF (125-134 kHz)
  • HF / NFC (13.56 MHz)
  • UHF / RAIN (860-960 MHz)
  • Microwave (2.45 GHz)
• By Application
  • Asset Tracking
  • Patient and Staff Tracking
  • Pharmaceutical and Supply-chain Tracking
  • Blood and Specimen Monitoring
  • Surgical Instrument Visibility
  • Biometric and Access Control
• By End User
  • Hospitals
  • Pharmaceutical Manufacturers
  • Clinics and Outpatient Centers
  • Research Labs and Biobanks
  • Contract Logistics and 3PL for Healthcare
• By Geography
  • North America
    • United States
    • Canada
    • Mexico
  • South America
    • Brazil
    • Argentina
    • Colombia
    • Rest of South America
  • Europe
    • Germany
    • United Kingdom
    • France
    • Italy
    • Spain
    • Nordics
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East and Africa
    • Middle East
      • Gulf Cooperation Council (GCC)
      • Turkey
      • Rest of Middle East
    • Africa
      • South Africa
      • Nigeria
      • Kenya
      • Rest of Africa

Geography Analysis

North America is leading the RFID market in the healthcare industry, with a 40.75% revenue share in 2025, driven by the adoption of regulatory support and mature infrastructure. The healthcare market in the region is dynamic and innovation-driven, with the U.S. at the forefront of adoption. The region benefits from regulatory pressure, technological maturity, and clinical demand for safety and efficiency. Furthermore, challenges such as cost and integration persist; however, the opportunities for smart, data-driven healthcare make RFID a cornerstone of future medical infrastructure.

The Asia-Pacific region emerges as the fastest-growing region, registering an 18.25% CAGR during the forecast period, driven by healthcare expansion and digital transformation. Europe maintains a robust position with regulatory-driven growth, whereas Latin America and MEA present emerging opportunities despite infrastructural and economic challenges. Across all regions, RFID is increasingly recognized as a critical enabler of patient safety, inventory efficiency, and operational resilience.

Europe's healthcare sector is embracing RFID technology, propelled by stringent traceability mandates, compliance with the Falsified Medicines Directive (FMD), and a robust push towards pharmacy automation. Hospitals are increasingly adopting RFID for asset management, aiming to reduce equipment losses and improve operational efficiency. In South America, countries such as Brazil and Chile are modernizing their supply chains and digitizing blood banks, leading to steady growth. However, budget constraints hinder large-scale deployments in hospitals. The Middle East and Africa see a surge in RFID adoption, driven by investments in smart hospitals in the Gulf Cooperation Council (GCC) region, a growing demand for RFID-based patient tracking, and government-backed initiatives for medicine authentication. While Africa as a whole faces challenges due to infrastructure gaps, there's a notable uptick in RFID adoption, especially in high-volume public facilities.

1. Zebra Technologies Corp.
2. Impinj Inc.
3. Avery Dennison Corp.
4. Honeywell International Inc.
5. Alien Technology LLC
6. Securitas Healthcare
7. GAO RFID Inc.
8. CCL Industries Inc.
9. S3Edge Inc.
10. Terso Solutions Inc.
11. Biolog-id SA
12. RF Technologies Inc.
13. STid Groupe
14. Spacecode Technologies SA
15. Identiv Inc.
16. Nedap N.V.
17. Tageos SAS
18. Denso Wave Inc.
19. Jadak (A Novanta Company)
20. SML Group Ltd.
21. Xerafy Ltd.
22. Invengo Technology Pte Ltd.
23. Turck Vilant Systems
24. MetraTec GmbH

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 Study Assumptions and Market Definition
• 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET LANDSCAPE

• 4.1 Market Overview
• 4.2 Market Drivers
  • 4.2.1 RFID-enabled Drug Authentication to Curb Counterfeits
  • 4.2.2 Automated Cold-Chain Compliance for Temperature-Sensitive Biologics
  • 4.2.3 Rapid Adoption of UHF Tags in Real-time Location Systems (RTLS)
  • 4.2.4 AI-powered Inventory Optimisation in Operating Rooms
  • 4.2.5 Mandated Unique Device Identification (UDI) Roll-outs
  • 4.2.6 Enhanced Patient Safety Through Automated Medication Verification
• 4.3 Market Restraints
  • 4.3.1 Interference of UHF RFID with MRI/CT Imaging Suites
  • 4.3.2 Capital-intensive Retrofit of Legacy Pharmacy Dispensing Cabinets
  • 4.3.3 Data-privacy Concerns in Patient-wearable Tags (EU GDPR)
  • 4.3.4 Competing BLE/Ultra-wideband RTLS Platforms
• 4.4 Industry Value Chain Analysis
• 4.5 Regulatory Outlook
  • 4.5.1 US FDA DSCSA Milestones
  • 4.5.2 EU FMD Safety Features
  • 4.5.3 China NMPA Medical-device Coding
• 4.6 Technological Outlook
  • 4.6.1 HF vs UHF vs RAIN Standards
  • 4.6.2 Cloud-native RFID Middleware
• 4.7 Porter's Five Forces
  • 4.7.1 Bargaining Power of Suppliers
  • 4.7.2 Bargaining Power of Buyers
  • 4.7.3 Threat of New Entrants
  • 4.7.4 Threat of Substitute Products
  • 4.7.5 Intensity of Competitive Rivalry

5 MARKET SIZE AND GROWTH FORECASTS (VALUE)

• 5.1 By Component
  • 5.1.1 Tags and Labels
  • 5.1.2 Readers / Antennas
  • 5.1.3 Middleware / Edge Servers
  • 5.1.4 Software and Analytics
  • 5.1.5 Services
• 5.2 By Tag Frequency
  • 5.2.1 LF (125-134 kHz)
  • 5.2.2 HF / NFC (13.56 MHz)
  • 5.2.3 UHF / RAIN (860-960 MHz)
  • 5.2.4 Microwave (2.45 GHz)
• 5.3 By Application
  • 5.3.1 Asset Tracking
  • 5.3.2 Patient and Staff Tracking
  • 5.3.3 Pharmaceutical and Supply-chain Tracking
  • 5.3.4 Blood and Specimen Monitoring
  • 5.3.5 Surgical Instrument Visibility
  • 5.3.6 Biometric and Access Control
• 5.4 By End User
  • 5.4.1 Hospitals
  • 5.4.2 Pharmaceutical Manufacturers
  • 5.4.3 Clinics and Outpatient Centers
  • 5.4.4 Research Labs and Biobanks
  • 5.4.5 Contract Logistics and 3PL for Healthcare
• 5.5 By Geography
  • 5.5.1 North America
    • 5.5.1.1 United States
    • 5.5.1.2 Canada
    • 5.5.1.3 Mexico
  • 5.5.2 South America
    • 5.5.2.1 Brazil
    • 5.5.2.2 Argentina
    • 5.5.2.3 Colombia
    • 5.5.2.4 Rest of South America
  • 5.5.3 Europe
    • 5.5.3.1 Germany
    • 5.5.3.2 United Kingdom
    • 5.5.3.3 France
    • 5.5.3.4 Italy
    • 5.5.3.5 Spain
    • 5.5.3.6 Nordics
    • 5.5.3.7 Rest of Europe
  • 5.5.4 Asia Pacific
    • 5.5.4.1 China
    • 5.5.4.2 Japan
    • 5.5.4.3 India
    • 5.5.4.4 Australia
    • 5.5.4.5 South Korea
    • 5.5.4.6 ASEAN
    • 5.5.4.7 Rest of Asia Pacific
  • 5.5.5 Middle East and Africa
    • 5.5.5.1 Middle East
      • 5.5.5.1.1 Gulf Cooperation Council (GCC)
      • 5.5.5.1.2 Turkey
      • 5.5.5.1.3 Rest of Middle East
    • 5.5.5.2 Africa
      • 5.5.5.2.1 South Africa
      • 5.5.5.2.2 Nigeria
      • 5.5.5.2.3 Kenya
      • 5.5.5.2.4 Rest of Africa

6 COMPETITIVE LANDSCAPE

• 6.1 Market Concentration
• 6.2 Strategic Moves
• 6.3 Market Share Analysis
• 6.4 Company Profiles (includes Global level Overview, Market level overview, Core Segments, Financials as available, Strategic Information, Market Rank/Share for key companies, Products and Services, and Recent Developments)
  • 6.4.1 Zebra Technologies Corp.
  • 6.4.2 Impinj Inc.
  • 6.4.3 Avery Dennison Corp.
  • 6.4.4 Honeywell International Inc.
  • 6.4.5 Alien Technology LLC
  • 6.4.6 Securitas Healthcare
  • 6.4.7 GAO RFID Inc.
  • 6.4.8 CCL Industries Inc.
  • 6.4.9 S3Edge Inc.
  • 6.4.10 Terso Solutions Inc.
  • 6.4.11 Biolog-id SA
  • 6.4.12 RF Technologies Inc.
  • 6.4.13 STid Groupe
  • 6.4.14 Spacecode Technologies SA
  • 6.4.15 Identiv Inc.
  • 6.4.16 Nedap N.V.
  • 6.4.17 Tageos SAS
  • 6.4.18 Denso Wave Inc.
  • 6.4.19 Jadak (A Novanta Company)
  • 6.4.20 SML Group Ltd.
  • 6.4.21 Xerafy Ltd.
  • 6.4.22 Invengo Technology Pte Ltd.
  • 6.4.23 Turck Vilant Systems
  • 6.4.24 MetraTec GmbH

7 MARKET OPPORTUNITIES AND FUTURE OUTLOOK

• 7.1 White-space and Unmet-need Assessment